Bal Pharma Limited (NSE:BALPHARMA)
India · Delayed Price · Currency is INR 71.87
-1.47 (-2.00%)
At close: Dec 26, 2025
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.15 billion as of December 26, 2025. Its market cap has decreased by -41.02% in one year.
Market Cap
1.15B
Enterprise Value
2.60B
Revenue
2.95B
Ranking
n/a
PE Ratio
16.80
Stock Price
71.87
Market Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.15B, an increase of 104.77%. That is a compound annual growth rate of 3.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 1.15B | -40.97% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | 797.20M | 35.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.17T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 923.52B |
| Mankind Pharma | 905.41B |
| Aurobindo Pharma | 703.58B |
| Fortis Healthcare | 681.50B |